This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) slid 3.34% to $118.07 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.84% to 10,737.51 and Dow Jones Industrial Average falling 1.54% to 29,225.61. This was the stock's second consecutive day of losses. Moderna Inc. closed $272.53 below its 52-week high ($390.60), which the company achieved on September 30th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 1.30% to $142.72, Amgen Inc. (AMGN) fell 1.11% to $228.41, and AstraZeneca PLC ADR (AZN.LN) rose 0.40% to $54.91. Trading volume (4.7 M) remained 32,345 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 29, 2022.
(END) Dow Jones Newswires
September 29, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.